N15: Influence of abundant nurse staffing on patient-reported outcomes among patients with inflammatory bowel disease in clinical remissionECCO’23 CopenhagenYear: 2023
Authors: Tanaka, M.(1)*;Kawakami, A.(1);Sakagami, K.(2);Terai, T.(3);Ito, H.(2);
(1)Tokyo Medical and Dental University TMDU- Graduate School of Health Care Sciences, Dep.Critical and Invasive-Palliative Care Nursing, Tokyo, Japan;(2)Kinshukai Infusion Clinic, Dep. Gastroenterology, Osaka, Japan;(3)Takeda Pharmaceutical Company Limited, Japan Medical Office, Tokyo, Japan;
N16: Exploring the factors that influence adjustment to and acceptance of an intestinal stoma for IBD: preliminary findingsECCO’23 CopenhagenYear: 2023
Authors: Essex, R.(1);Burch, J.(2);Kemp, K.(3);Duncan, J.(4);Monks, C.(5);Dibley, L.(6)*;
(1)University of Greenwich, Institute for Lifecourse Development, London, United Kingdom;(2)St Mark's Hospital, Nurse Education, London, United Kingdom;(3)Manchester Royal Infirmary, Department of Gastroenterology, Manchester, United Kingdom;(4)Takeda UK, Clinical Education, London, United Kingdom;(5)University of Greenwich, School of Human Sciences- Institute for Lifecourse Development, London, United Kingdom;(6)University of Greenwich, School of Health Sciences- Institute for Lifecourse Development, London, United Kingdom;PRESTO PPI team
N18: Exploring the experiences of UK-dwelling Bangladeshi native language-speaking patients with Inflammatory Bowel Disease: preliminary findings from a qualitative studyECCO’23 CopenhagenYear: 2023
Authors: Ahmed, S.(1);Singh, H.(2,3);Newton, P.(1)*;Ojo, O.(1);Dibley, L.(1);
(1)University of Greenwich, Institute for Lifecourse Development, London, United Kingdom;(2)Research Champion with CCUK, None, Hatfield, United Kingdom;(3)Expert by Experience with Guts UK, None, London, United Kingdom;
N21: Patient education is (sometimes) better than cure.ECCO’23 CopenhagenYear: 2023
Authors: Müskens, B.(1)*;
(1)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;P. (Petra) Waayenberg MSc K.H.N. (Nanne) De Boer MD PhDA S. (Sigrid) Müller-Schotte OD PhD FAAOB
N23: Burnout among European IBD specialists – a survey supported by ECCOECCO’23 CopenhagenYear: 2023
Authors: Sánta, A.(1)*;Volosin, M.(2);Farkas, K.(1);Keresztes, C.(3);Rafael , B.(4);Molnár, T.(1);
(1)Albert Szent-Györgyi Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)University of Szeged, Institute of Psychology, Szeged, Hungary;(3)Albert Szent-Györgyi Medical School- University of Szeged, Department for Medical Communication and Translation Studies, Szeged, Hungary;(4)Albert Szent-Györgyi Medical School- University of Szeged, Department of Preventive Medicine, Szeged, Hungary;
N24: At Home Calprotectin a United Kingdom Patient Perspectives and Tertiary Center ExperienceECCO’23 CopenhagenYear: 2023
Authors: Avery, P.(1)*;Adio, J.(1);Cornford, R.(2);Younge, L.(1);
(1)St Marks Hospital and Academic Institute, Inflammatory Bowel Disease, London, United Kingdom;(2)Northwick Park Hospital, Clinical Biochemistry, London, United Kingdom;
N25: Diagnostic delay and economic burden in ibd: a multicenter italian experience in patients treated with biologicsECCO’23 CopenhagenYear: 2023
Authors: Mocci, G.(1);Onidi, F.M.(1)*;Magri', S.(2);Bodini, G.(3);Lorenzetti, R.(4);Binaghi, L.(1);Dore, M.F.(1);Martello , S.(1);Usai Satta, P.(1);Elisei, W.(5);Tursi, A.(6);
(1)Arnas- Brotzu Hospital- Gastroenterology Unit, Department of Internal Medicine, Cagliari, Italy;(2)Emergency Hospital company - Gastroenterology Unit, Department of Internal Medicine, Catania, Italy;(3)Policlinico S. Martino- Gastroenterology Unit, Department of Internal Medicine, Genova, Italy;(4)Nuovo Regina Margherita - Gastroenterology Unit, Department of Internal Medicine, Roma, Italy;(5)S.Camillo Fonanini Hospital, Division of Gastroenterology, Roma, Italy;(6)Gastroenterologoly Unit- territorial, Department of Internal Medicine, Andria, Italy;
N26: Help-seeking experiences of patients with Inflammatory Bowel Disease from healthcare professionals: A qualitative descriptive studyECCO’23 CopenhagenYear: 2023
Authors: Byron, C.(1,2)*;Lehane, E.(2);Burton, A.(2);Cornally , N.(2);
(1)Cork University Hospital, Gastroenterology, Cork, Ireland;(2)University College Cork, School of Nursing and Midwifery, Cork, Ireland;
N27: Living well with IBD; An online survey from the UKECCO’23 CopenhagenYear: 2023
Authors: RadfordBSc- MSc- PGCert- PhD student, S.(1)*;Sawyer, R.(2);
(1)Nottingham University Hospitals NHS Trust, NIHR Nottingham Biomedical Research Centre- Gastrointestinal and Liver disorders, Nottingham, United Kingdom;(2)The Bottom Line IBD, The Bottom Line IBD, London, United Kingdom;
N28: Satisfaction with telemedicine programs in inflammatory bowel disease: a natiowise multicenter studyECCO’23 CopenhagenYear: 2023
Authors: Cano Sanz, N.(1)*;Serrano Redondo, M.(2);Jurado Monroy, R.M.(3);Suárez Álvarez, P.(1);García Prada, M.(1);Latras Cortés, I.(1);Sierra Ausín, M.(1);
(1)University Hospital of León, Department of Gastroenterology - IBD Unit, León, Spain;(2)University Hospital Marques de Valdecilla, Department of Gastroenterology - IBD Unit, Santander, Spain;(3)Puertollano Hospital, Department of Gastroenterology - IBD Unit, Puertollano, Spain;
N31: Nothing about us, without us: Developing a reliable IBD information source on sexual well-being by patients and for patientsECCO’23 CopenhagenYear: 2023
Authors: Fourie, S.(1);Johnstone, L.(1)*;Czuber-Dochan, W.(2);
(1)University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom;(2)King's College of London, Florence Nightingale Faculty of Nursing- Midwifery and palliative Care, London, United Kingdom;
OP01: Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Verstockt, S.(1)*;Machiels, K.(1);Dehairs, J.(2);Rems, K.(1);De Greef, I.(1);Jans, D.(3);Sabino, J.(1,4);Ferrante, M.(1,4);Vermeire, S.(1,4);Verstockt, B.(1,4);
(1)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing CHROMETA, Leuven, Belgium;(2)KU Leuven, Department of Oncology, Leuven, Belgium;(3)KU Leuven, Department of Human Genetics, Leuven, Belgium;(4)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
OP02: Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn's disease patients stopping infliximabECCO’23 CopenhagenYear: 2023
Authors: PierreDr., N.(1)*;Huynh-Thu, V.A.(2);Baiwir, D.(3);Mazzucchelli, G.(4);Fléron, M.(3);Trzpiot, L.(4);Eppe, G.(4);Laharie, D.(5);Satsangi, J.(6);Colombel, J.F.(7);Hertervig, E.(8);Meuwis, M.A.(1);Louis, E.(9);
(1)University of Liege, Laboratory of Translational Gastroenterology, Liege, Belgium;(2)University of Liege, Department of Electrical Engineering and Computer Science, Liege, Belgium;(3)University of Liege, GIGA Proteomics Facility, Liege, Belgium;(4)University of Liege, Laboratory of Mass Spectrometry, Liege, Belgium;(5)Centre Hospitalier Universitaire de Bordeaux, Service d'Hépato-gastroentérologie et oncologie digestive, Bordeaux, France;(6)John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom;(7)Icahn School of Medicine at Mount Sina, Division of Gastroenterology, New York, United States;(8)Skane University Hospital, Department of Gastroenterology, Lund, Sweden;(9)Liege University Hospital, Hepato-Gastroenterology and Digestive Oncology Department, Liege, Belgium;GETAID and the SPARE-Biocycle research group
OP03: Highly stable epigenome-wide peripheral blood DNA methylation signatures accurately predict endoscopic response to adalimumab, vedolizumab and ustekinumab in Crohn's disease patients: The EPIC-CD studyECCO’23 CopenhagenYear: 2023
Authors: JoustraMD., V.(1)*;Li Yim, A.(2,3);Hageman, I.(2);Levin, E.(4);Noble, A.(5);Chapman, T.(6);McGregor, C.(6);Adams, A.(6);Satsangi, J.(6);de Jonge, W.(2);Henneman, P.(3);D'Haens, G.(1);
(1)Amsterdam UMC location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC location AMC, Tytgat institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Amsterdam UMC location AMC, Genome Diagnostics Laboratory- Department of Clinical Genetics, Amsterdam, The Netherlands;(4)Horaizon, bv, Delft, The Netherlands;(5)Oxford University - Hospitals NHS Foundation Trust - John Radcliffe Hospital, Translational Gastroenterology Unit - NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom;(6)Oxford University- Hospitals NHS Foundation Trust- John Radcliffe Hospital, Translational Gastroenterology Unit- NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom;on behalf of the EPIC-CD Consortium
